At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ICAD icad
Not Yet Opened 05-13 16:00:00 EDT
1.56
+0.05
+3.31%
盘后1.56
+0.000.00%
16:00 EDT
High1.59
Low1.50
Vol96.71K
Open1.51
D1 Closing1.51
Amplitude5.83%
Mkt Cap41.13M
Tradable Cap38.72M
Total Shares26.37M
T/O150.57K
T/O Rate0.39%
Tradable Shares24.82M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
UPDATE - iCAD to Report First Quarter 2024 Financial Results on May 15, 2024
iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.